HCPCS Level IIdrugActive
J0225
Inj, vutrisiran, 1 mg
BETOS: O1E
Effective: 2023-01-01
Description
Injection, vutrisiran, 1 mg
Medicare Part B Drug Pricing
Average Sales Price (ASP) data for Q1 2026
Drug Name
Amvuttra
Manufacturer
Alnylam Pharmaceuticals, Inc.
HCPCS Dosage
1 MG
Billing Units
25.0000
1
NDC Products
asp
Pricing Source
Medicare Part B drugs are reimbursed at ASP + 6%. Pricing updates quarterly based on manufacturer-reported data.